IL6 and Cirrhosis: Some studies have shown potential effects of Cit on reducing inflammatory markers such as tumor necrosis factor α (TNF-α) and interleukin-6 (IL-6) [12, 15, 16], which can prevent development of disease to severe conditions such as NASH and cirrhosis [17].